Clinical Oncology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Carcinoma Genetics
Scientists at University of Tokushima, Institute of Health Bioscience report research in carcinoma genetics
June 15th, 2009
Fresh data on carcinoma are presented in the report 'Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.' "The activation of oncogenes is an important step in tumorigenesis, and recently, oncogene-induced senescence (OIS) was proposed as a critical barrier against malignant transformation in normal primary cells. The aim of this study was to examine the activation of fibroblast growth factor receptor 3 (FGFR3) as an oncogene product and OIS in human skin tumours," scientists in Japan report. "We investigated the activation of FGFR3 and OIS by mutation and immunohistochemical analysis in skin tumours, including seborrhoeic...
Source: Clinical Oncology Week (2009-06-15)
|
